[1]
J.-N. Boursiquot and H. Chapdelaine, “Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada”, Can Allergy Immunol Today, vol. 5, no. s01, pp. 2–9, Mar. 2025.